Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GPR3 | P46089 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | TOP2A | P11388 | 1/20 | 0.37 |
| ▸ | NCF1 | P14598 | 1/20 | 0.35 |
| ▸ | PI4KA | P42356 | 1/20 | 0.35 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.35 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.35 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30402017 | 1.00 | ALDH1A1 (0.47) | ALDH1A1HSD17B10GPR3KDM4EERN1 | |
| Ammonia Solution, Strong SCHEMBL6783413 | 0.98 | ALDH1A1 (0.45) | ALDH1A1HSD17B10GPR3KDM4EERN1 | |
| Hydrochloric Acid SCHEMBL10466114 | 0.98 | ALDH1A1 (0.45) | ALDH1A1HSD17B10GPR3KDM4EERN1 | |
| SCHEMBL7101151 | 0.78 | PI4KA (0.42) | ALDH1A1HSD17B10GPR3KDM4ETOP2A | |
| SCHEMBL3943646 | 0.76 | MAPT (0.58) | ALDH1A1HSD17B10KDM4EERN1NCF1 | |
| SCHEMBL2809627 | 0.76 | LMNA (0.49) | ALDH1A1HSD17B10KDM4E | |
| SCHEMBL19118754 | 0.75 | KDM4E (0.46) | ALDH1A1HSD17B10GPR3KDM4EERN1 | |
| SCHEMBL10465960 | 0.74 | NR4A2 (0.42) | ALDH1A1HSD17B10ALOX15 | |
| SCHEMBL2809624 | 0.73 | KDM4E (0.45) | ALDH1A1HSD17B10KDM4EALOX15SMN1; SMN2 | |
| SCHEMBL29871387 | 0.72 | CYP3A4 (0.47) | ALDH1A1HSD17B10GPR3KDM4ENCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9546184-B2 | Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-01-17 | — | — | US | claimed |
| US-20150266901-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES CO (US) | 2015-09-24 | — | — | US | claimed |
| US-4904669-A | Thiazolo/4,5-c/quinolines as major tranquilizers | EGIS GYOGYSZERGYAR (HU) | 1990-02-27 | — | — | US | claimed |
| EP-3784670-B1 | NLRP3 MODULATORS | INNATE TUMOR IMMUNITY INC (US) | 2023-11-29 | — | — | EP | disclosed |
| US-20230093782-A9 | SUBUNIT VACCINE CONSTRUCTS FOR FLAVIVIRUSES | UNIV MINNESOTA (US) | 2023-03-23 | — | — | US | disclosed |
| US-20220054617-A1 | SUBUNIT VACCINE CONSTRUCTS FOR FLAVIVIRUSES | UNIV MINNESOTA (US) | 2022-02-24 | — | — | US | disclosed |
| WO-2020123759-A1 | SUBUNIT VACCINE CONSTRUCTS FOR FLAVIVIRUSES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2020-06-18 | — | — | WO | disclosed |
| US-20180057509-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES CO (US) | 2018-03-01 | — | — | US | disclosed |
| US-20170088559-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES CO (US) | 2017-03-30 | — | — | US | disclosed |
| US-9546184-B2 | Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-01-17 | — | — | US | disclosed |
| US-20150266901-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES CO (US) | 2015-09-24 | — | — | US | disclosed |
| US-20030045545-A1 | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof | 3M INNOVATIVE PROPERTIES COMPANY | 2003-03-06 | — | — | US | disclosed |
| US-6440992-B1 | ARE IMMUNOMODULATORS AND INDUCE CYTOKINE BIOSYNTHESIS, INCLUDING INTERFERON AND/OR TUMOR BIOSYNTHESIS, NECROSIS FACTOR, AND INHIBIT T-HELPER-TYPE 2 IMMUNE RESPONSE; USEFUL FOR THERAPY OF VIRAL AND NEOPLASTIC DISEASES | 3M INNOVATIVE PROPERTIES COMPANY | 2002-08-27 | — | — | US | disclosed |
| US-20020072528-A1 | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof | 3M INNOVATIVE PROPERTIES COMPANY | 2002-06-13 | — | — | US | disclosed |
| US-6323200-B1 | THE COMPOUNDS ARE IMMUNOMODULATORS AND INDUCE CYTOKINE BIOSYNTHESIS, INCLUDING INTERFERON AND/OR TUMOR BIOSYNTHESIS, NECROSIS FACTOR, AND INHIBIT THE T-HELPER-TYPE 2 IMMUNE RESPONSE. | 3M INNOVATIVE PROPERTIES COMPANY | 2001-11-27 | — | — | US | disclosed |
| EP-1100802-A1 | OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF | 3M Innovative Properties Company (US) | 2001-05-23 | — | — | EP | disclosed |
| US-6110929-A | IMMUNOMODULATORS WHICH INDUCE CYTOKINE BIOSYNTHESIS, INCLUDING INTERFERON AND/OR TUMOR BIOSYNTHESIS, NECROSIS FACTOR AND INHIBIT T-HELPER-TYPE 2 IMMUNE RESPONSE; FOR TREATMENT OF VIRAL AND NEOPLASTIC DISEASES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-08-29 | — | — | US | disclosed |
| WO-2000006577-A1 | OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| US-4904669-A | Thiazolo/4,5-c/quinolines as major tranquilizers | EGIS GYOGYSZERGYAR (HU) | 1990-02-27 | — | — | US | disclosed |
| US-4904669-A | Thiazolo/4,5-c/quinolines as major tranquilizers | EGIS GYOGYSZERGYAR (HU) | 1990-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266901-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | IL2, IFNG, TSLP | ALDH1A1 624/4885HSD17B10 1809/4885GPR3 2396/4885 |
| US-20020072528-A1 | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof | IFNG, THPO, IL2 | ALDH1A1 2933/4885HSD17B10 2419/4885GPR3 4235/4885 |
| US-20170088559-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | IL2, IFNG, TSLP | ALDH1A1 624/4885HSD17B10 1809/4885GPR3 2396/4885 |
| US-20180057509-A1 | ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | IL2, IFNG, TSLP | ALDH1A1 624/4885HSD17B10 1809/4885GPR3 2396/4885 |
| US-20220054617-A1 | SUBUNIT VACCINE CONSTRUCTS FOR FLAVIVIRUSES | LRBA, CRYAA, DDOST | ALDH1A1 4304/4885HSD17B10 2051/4885GPR3 3601/4885 |
| US-20030045545-A1 | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof | IFNG, THPO, IL2 | ALDH1A1 2933/4885HSD17B10 2419/4885GPR3 4235/4885 |
| US-20230093782-A9 | SUBUNIT VACCINE CONSTRUCTS FOR FLAVIVIRUSES | FNTB, LRBA, MAVS | ALDH1A1 4370/4885HSD17B10 2155/4885GPR3 3445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.